Paper42957740PubMed
Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears.
Eckardt JN and 21 others. NPJ Precis Oncol, 2026.
Cite this record
ConductScience Library. Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears. Papers, record 42957740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42957740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears.
- Journal
- NPJ Precis Oncol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-01
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27295650 | Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks. | IEEE Trans Pattern Anal Mach Intell | 2017 | https://conductscience.org/library/papers/27295650 | PubMed |
| 2 | 35732831 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732831 | PubMed |
| 3 | 34794176 | Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study. | Blood Adv | 2022 | https://conductscience.org/library/papers/34794176 | PubMed |
| 4 | 39475462 | FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39475462 | PubMed |
| 5 | 33420381 | Deep learning-enabled medical computer vision. | NPJ Digit Med | 2021 | https://conductscience.org/library/papers/33420381 | PubMed |
| 6 | 30692099 | FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30692099 | PubMed |
| 7 | 38539070 | Slideflow: deep learning for digital histopathology with real-time whole-slide visualization. | BMC Bioinformatics | 2024 | https://conductscience.org/library/papers/38539070 | PubMed |
| 8 | 37967385 | Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears. | Blood Adv | 2024 | https://conductscience.org/library/papers/37967385 | PubMed |
| 9 | 38600315 | Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. | Leukemia | 2024 | https://conductscience.org/library/papers/38600315 | PubMed |
| 10 | 36781917 | Detection of acute promyelocytic leukemia in peripheral blood and bone marrow with annotation-free deep learning. | Sci Rep | 2023 | https://conductscience.org/library/papers/36781917 | PubMed |
| 11 | 39300079 | Current status and research directions in acute myeloid leukemia. | Blood Cancer J | 2024 | https://conductscience.org/library/papers/39300079 | PubMed |
| 12 | 20171147 | The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20171147 | PubMed |
| 13 | 34497326 | Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. | Leukemia | 2022 | https://conductscience.org/library/papers/34497326 | PubMed |
| 14 | 33990660 | Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features. | NPJ Precis Oncol | 2021 | https://conductscience.org/library/papers/33990660 | PubMed |
| 15 | 35193533 | Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35193533 | PubMed |
| 16 | 36921004 | Explainable AI identifies diagnostic cells of genetic AML subtypes. | PLOS Digit Health | 2023 | https://conductscience.org/library/papers/36921004 | PubMed |
| 17 | 40617702 | AML diagnostics in the 21st century: Use of AI. | Semin Hematol | 2025 | https://conductscience.org/library/papers/40617702 | PubMed |
| 18 | 35767897 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. | Blood | 2022 | https://conductscience.org/library/papers/35767897 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42957740
GET https://conductscience.org/api/papers/v1/42957740/authors?page=2